Home / Market News / $INGN

$INGN news and market catalysts

The 4 most recent market catalysts affecting $INGN, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

4 catalysts 2 high impact 2 bullish 1 bearish Medical Devices
Nov 6, 2026 Corporate Catalyst Neutral Impact 85
Inogen Reports Q3 2026 Results, Appoints New CEO, and Announces Strategic Divestiture
Inogen's Q3 2026 results show a 2.4% year-over-year revenue decrease and a $14.8 million GAAP loss, indicating ongoing financial challenges. The appointment of a new CEO, Andy Redi…
Sep 30, 2026 Corporate Catalyst Bullish Impact 65
Inogen Agrees To Divest Its U.S. Oxygen Rental Operations To Rotech Healthcare For $25M
Inogen, a medical technology company, is divesting its U.S. oxygen rental operations to Rotech Healthcare for an estimated $25 million. This move is significant as it indicates Ino…
Aug 6, 2026 Corporate Catalyst Bearish Impact 75
Inogen Lowers FY2026 Sales Guidance from $366.000M-$373.000M to $355.000M-$361.000M vs $369.267M Est
Inogen (INGN) has lowered its FY2026 sales guidance from an initial range of $366.0 million-$373.0 million to a new range of $355.0 million-$361.0 million. This revised outlook is …
Aug 6, 2026 Corporate Catalyst Bullish Impact 92
Inogen Q2 Sales $95.084M Miss $95.233M Estimate
Inogen's Q2 sales of $95.084 million missed analyst consensus by a narrow margin of 0.16%. While the miss is small, any deviation from expectations, especially on the downside for …
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.